StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
Publishing Date
2024 - 04 - 24
11
2023 - 12 - 18
10
2023 - 12 - 13
8
2023 - 12 - 12
11
2023 - 12 - 11
13
2023 - 11 - 03
10
2023 - 11 - 02
8
2023 - 10 - 30
8
2023 - 10 - 16
10
2023 - 09 - 26
10
2023 - 09 - 07
8
2023 - 07 - 17
12
2023 - 06 - 05
13
2023 - 05 - 25
10
2023 - 05 - 16
11
2023 - 05 - 09
8
2023 - 04 - 26
10
2023 - 04 - 17
8
2023 - 03 - 28
8
2023 - 02 - 16
8
2022 - 11 - 03
9
2022 - 09 - 16
9
2022 - 07 - 28
8
2022 - 06 - 22
9
2022 - 06 - 10
9
2022 - 05 - 23
8
2022 - 02 - 25
9
2022 - 02 - 14
9
2021 - 12 - 13
19
2021 - 12 - 09
16
2021 - 12 - 06
8
2021 - 11 - 30
8
2021 - 11 - 29
12
2021 - 11 - 15
9
2021 - 11 - 12
12
2021 - 11 - 08
8
2021 - 10 - 25
8
2021 - 10 - 15
9
2021 - 10 - 07
7
2021 - 10 - 04
8
2021 - 09 - 29
7
2021 - 09 - 28
7
2021 - 09 - 27
11
2021 - 09 - 20
13
2021 - 09 - 17
10
2021 - 09 - 16
9
2021 - 09 - 13
12
2021 - 06 - 29
7
2021 - 06 - 28
7
2021 - 06 - 25
10
2021 - 06 - 11
9
2021 - 06 - 07
8
2021 - 05 - 24
7
2021 - 05 - 21
15
2021 - 05 - 20
8
2021 - 05 - 11
7
2021 - 04 - 12
7
2021 - 03 - 24
8
2021 - 03 - 15
7
2020 - 12 - 09
7
Sector
Health technology
8
Tags
Alzheimer
3
Alzheimer's
3
Alzheimer’s
3
Antibody
4
Application
8
Approval
6
Biocapital
4
Bioscience
3
Biotech
4
Breast cancer
3
Cancer
7
Cell carcinoma
4
Ceo
3
Clinical-trials-phase-ii
6
Clinical-trials-phase-iii
5
Collaboration
6
Commercialization
3
Conference
37
Covid
11
Covid-19
3
Designation
5
Device
3
Disease
5
Distribution
4
Drug
4
Energy
10
Enroll
4
Europe
9
Ev
3
Expansion
6
Fda
8
Financial results
7
Growth
13
Health
5
Hotel
4
Iot
8
Leo
4
Merge
5
N/a
312
Offering
15
Partnership
4
People
11
Pharm-country
5
Phase 2
11
Phase 3
8
Positive
8
Presentation
12
Program
7
Research
23
Results
20
Set
4
Software
5
Spac
4
Space
4
Technology
12
Test
4
Therapy
8
Treatment
8
Trial
21
Vaccine
7
Entities
Atara biotherapeutics, inc.
1
Beyondspring, inc.
2
Delcath systems, inc.
1
Eli lilly and company
2
Greenwich lifesciences, inc.
1
Veru inc.
1
Symbols
ATRA
1
BYSI
2
DCTH
1
GLSI
1
LLY
2
VERU
1
Exchanges
Nasdaq
6
Nyse
2
Crawled Date
2021 - 06 - 07
8
Crawled Time
01:00
1
07:00
1
12:00
4
13:00
1
15:15
1
Source
www.biospace.com
5
www.globenewswire.com
2
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 06 - 07
tags :
Positive
save search
Atara Biotherapeutics Presents Positive Tab-cel® Long-Term Overall Survival Data for Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease After Solid Organ Transplant at ATC 2021 Virtual Connect
Published:
2021-06-07
(Crawled : 15:15)
- biospace.com/
ATRA
|
$0.7101
-1.18%
-1.2%
700K
|
Health Technology
|
-94.61%
|
O:
0.15%
H:
7.69%
C:
6.52%
disease
positive
iot
tab-cel
cel
Veru Announces Positive Phase 2 Clinical Data: Efficacy of Enobosarm Therapy Correlates with Androgen Receptor Levels in AR+ER+HER2- Metastatic Breast Cancer Presented at the 2021 ASCO Annual Meeting
Published:
2021-06-07
(Crawled : 13:00)
- globenewswire.com
VERU
|
$1.325
3.92%
3.77%
1.5M
|
Health Technology
|
-84.88%
|
O:
0.92%
H:
5.56%
C:
1.82%
phase 2
positive
therapy
cancer
breast cancer
her2+
her2-
her2
metastatic breast cancer
Positive Preliminary Results from Delcath Systems’ FOCUS Trial Presented at the 2021 ASCO Annual Meeting
Published:
2021-06-07
(Crawled : 12:00)
- biospace.com/
DCTH
|
$5.48
-2.14%
-2.19%
190K
|
Health Technology
|
-49.35%
|
O:
7.99%
H:
1.2%
C:
-5.59%
positive
results
trial
Greenwich LifeSciences Publishes Additional Positive Safety Data from GP2 Phase IIb Trial at ASCO 2021, Confirming that GP2 Treatment to Prevent Metastatic Breast Cancer Recurrence is Well Tolerated
Published:
2021-06-07
(Crawled : 12:00)
- biospace.com/
GLSI
|
$12.6
-4.11%
-4.29%
29K
|
Health Technology
|
-67.69%
|
O:
2.0%
H:
1.21%
C:
-4.94%
treatment
positive
cancer
breast cancer
trial
metastatic breast cancer
BeyondSpring Announces Three Presentations Highlighting Positive Clinical Outcome Data from the Phase 3 Program of Plinabulin in Combination with Pegfilgrastim for the Prevention of Chemotherapy-Induced Neutropenia at the American Society of Clinical Oncology (ASCO) Annual Meeting
Published:
2021-06-07
(Crawled : 12:00)
- globenewswire.com
BYSI
|
$2.46
7.42%
6.91%
97K
|
Health Technology
|
-77.29%
|
O:
2.99%
H:
11.25%
C:
9.98%
presentation
positive
therapy
phase 3
plinabulin
BeyondSpring Announces Three Presentations Highlighting Positive Clinical Outcome Data from the Phase 3 Program of Plinabulin in Combination with Pegfilgrastim for the Prevention of Chemotherapy-Induced Neutropenia at the ASCO Annual Meeting
Published:
2021-06-07
(Crawled : 12:00)
- biospace.com/
BYSI
|
$2.46
7.42%
6.91%
97K
|
Health Technology
|
-77.29%
|
O:
2.99%
H:
11.25%
C:
9.98%
presentation
positive
therapy
phase 3
plinabulin
AnHeart and Innovent Releases Preliminary Results from the Phase II TRUST Trial of Taletrectinib in ROS1 Fusion Positive NSCLC at the ASCO 2021 Annual Meeting
Published:
2021-06-07
(Crawled : 07:00)
- biospace.com/
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
262.44%
|
O:
-0.01%
H:
15.52%
C:
10.16%
heart
positive
results
trial
Innovent and AnHeart Release Preliminary Results from the Phase II TRUST Trial of Taletrectinib in ROS1 Fusion Positive NSCLC at the ASCO 2021 Annual Meeting
Published:
2021-06-07
(Crawled : 01:00)
- prnewswire.com
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
262.44%
|
O:
-0.01%
H:
15.52%
C:
10.16%
heart
positive
results
trial
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.